ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.677,87
-0,45%
S&P 500
5.298,95
-0,11%
Dow Jones
38.796,19
-0,70%
Euro vs US Dollar
1,0865
0,03%
Bitcoin
67.841,80
-2,24%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Sight Sciences Inc (SGHT)

  7. Sight Sciences Inc (SGHT) News

SGHT

Sight Sciences (SGHT)

Sight Sciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:SGHT
DatumZeitQuelleÜberschriftSymbolFirma
28/05/202414h30GlobeNewswire Inc.Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate, and Advanced GlaucomaNASDAQ:SGHTSight Sciences Inc
21/05/202402h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGHTSight Sciences Inc
17/05/202422h16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SGHTSight Sciences Inc
07/05/202422h05GlobeNewswire Inc.Sight Sciences to Present at the Upcoming Bank of America Healthcare ConferenceNASDAQ:SGHTSight Sciences Inc
06/05/202422h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SGHTSight Sciences Inc
02/05/202422h05GlobeNewswire Inc.Sight Sciences Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Financial GuidanceNASDAQ:SGHTSight Sciences Inc
29/04/202414h05GlobeNewswire Inc.Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma SurgeryNASDAQ:SGHTSight Sciences Inc
18/04/202422h05GlobeNewswire Inc.Sight Sciences to Report First Quarter Financial Results on May 2, 2024NASDAQ:SGHTSight Sciences Inc
10/04/202422h05GlobeNewswire Inc.Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2NASDAQ:SGHTSight Sciences Inc
02/04/202422h05GlobeNewswire Inc.Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual MeetingNASDAQ:SGHTSight Sciences Inc
26/03/202421h05GlobeNewswire Inc.Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare ConferenceNASDAQ:SGHTSight Sciences Inc
07/03/202422h05GlobeNewswire Inc.Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial GuidanceNASDAQ:SGHTSight Sciences Inc
22/02/202422h05GlobeNewswire Inc.Sight Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024NASDAQ:SGHTSight Sciences Inc
17/02/202403h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGHTSight Sciences Inc
17/02/202403h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGHTSight Sciences Inc
17/02/202403h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGHTSight Sciences Inc
17/02/202403h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGHTSight Sciences Inc
17/02/202403h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGHTSight Sciences Inc
17/02/202403h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGHTSight Sciences Inc
17/02/202403h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGHTSight Sciences Inc
17/02/202403h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGHTSight Sciences Inc
17/02/202403h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGHTSight Sciences Inc
17/02/202403h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGHTSight Sciences Inc
17/02/202403h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGHTSight Sciences Inc
17/02/202403h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGHTSight Sciences Inc
17/02/202403h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGHTSight Sciences Inc
17/02/202403h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGHTSight Sciences Inc
17/02/202403h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGHTSight Sciences Inc
14/02/202423h24Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SGHTSight Sciences Inc
14/02/202422h05GlobeNewswire Inc.Sight Sciences Announces European Launch of the Ergo-Series of the OMNI® Surgical System at the ESCRS Winter MeetingNASDAQ:SGHTSight Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:SGHT

Kürzlich von Ihnen besucht

LATK
MFLOKIADAUSDT
MiniFlokiADA
CREX
TGIBTC
Taghi
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten